Pharmaceutical Executive-09-01-2019

Pharmaceutical Executive

Pharm Exec's 18th Annual Industry Audit

September 26, 2019

Features

39

9

Pharm Exec’s latest analysis of financial performance reveals that it’s those drugmakers maximizing the difference between the value and the cost of their capital investments that are delivering the most bang for the buck to shareholders.

Setting Your Launch Path

September 12, 2019

From the Editor

39

9

There are many factors involved in launching a drug but one prevailing goal: brand awareness. I caught up with Fingerpaint's Bryan O’Malley, who shared some of today's key digital trends affecting that mission.

Pre-launch Prep: The Modern Protocol

September 11, 2019

Features

39

9

Tech-driven changes to training and learning systems-and how brand information is provided and shared-are overhauling approaches to sales rep preparation.

Post-Launch Birthday: The Time to Refine

September 10, 2019

Features

39

9

Following a new product’s first year on the market, there are four key ways companies can refine commercial strategies to maximize product sales.

Product Launch: Five Paths Forward

September 10, 2019

Features

39

9

Pharm Exec’s annual feature profiling a selection of notable biopharma brands focuses this year on new beginnings and new promise-spotlighting five products with compelling product launch stories that tie strongly with the industry’s broader and evolving market-entry landscape.

Pharmaceutical Executive, September 2019 Issue (PDF)

September 01, 2019

Issue PDF

39

9

Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.

Country Report: China

September 01, 2019

Special Sponsored Section

39

9

A decade into China’s far-reaching healthcare reforms-which began with the implementation of universal, albeit rudimentary, medical insurance-the pace of change and transformation within the country’s life sciences industry shows no signs of abating.

Other Products to Watch

September 01, 2019

Features

39

9

Amid the noteworthy product launches profiled this year by Pharm Exec are four more therapy trailblazers worth highlighting.